Charles Conway - Net Worth and Insider Trading
Charles Conway Net Worth
The estimated net worth of Charles Conway is at least $56,320 dollars as of 2024-05-13. Charles Conway is the Chief Scientific Officer of Biohaven Pharmaceutical Holding Co Ltd and owns about 4,000 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $56,320. Details can be seen in Charles Conway's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles Conway has not made any transactions after 2017-05-09 and currently still holds the listed stock(s).
Transaction Summary of Charles Conway
Charles Conway Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Conway owns 1 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) .
Click here to see the complete history of Charles Conway’s form 4 insider trades.
Insider Ownership Summary of Charles Conway
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2017-05-09 | Chief Scientific Officer |
Charles Conway Latest Holdings Summary
Charles Conway currently owns a total of 1 stock. Charles Conway owns 4,000 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of May 9, 2017, with a value of $56,320.
Latest Holdings of Charles Conway
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2017-05-09 | 4,000 | 14.08 | 56,320 |
Holding Weightings of Charles Conway
Charles Conway Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Conway has made a total of 0 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 4,000 shares on May 9, 2017, which cost Charles Conway around $68,000.
Insider Trading History of Charles Conway
- 1
Charles Conway Trading Performance
GuruFocus tracks the stock performance after each of Charles Conway's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Conway is 21.81%. GuruFocus also compares Charles Conway's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Conway within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Conway's insider trading performs compared to the benchmark.
Performance of Charles Conway
Charles Conway Ownership Network
Ownership Network List of Charles Conway
Ownership Network Relation of Charles Conway
Charles Conway Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
Charles Conway is the Chief Scientific Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
Charles Conway Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Conway. You might contact Charles Conway via mailing address: C/o Biohaven Pharmaceutical Holding Comp 234 Church Street New Haven Ct 06510.